SIMVASTATIN INHIBITS THE OXIDATION OF LOW-DENSITY LIPOPROTEINS BY ACTIVATED HUMAN MONOCYTE-DERIVED MACROPHAGES

被引：173

作者：

GIROUX, LM ^{[1
]}

DAVIGNON, J ^{[1
]}

NARUSZEWICZ, M ^{[1
]}

机构：

[1] CLIN RES INST MONTREAL, HYPERLIPIDEMIA & ATHEROSCLEROSIS RES GRP, 110 PINE AVE W, MONTREAL H2W 1R7, QUEBEC, CANADA

来源：

BIOCHIMICA ET BIOPHYSICA ACTA | 1993年 / 1165卷 / 03期

关键词：

SIMVASTATIN; MACROPHAGE; OXIDIZED LDL; LDL;

D O I：

10.1016/0005-2760(93)90145-Y

中图分类号：

Q5 [生物化学]; Q7 [分子生物学];

学科分类号：

071010 ; 081704 ;

摘要：

Human monocyte-derived macrophages treated with increasing concentrations of the HMG-CoA reductase inhibitor, simvastatin, showed a dose-dependent decrease in superoxide formation in response to activation by phorbol myristate acetate. As a consequence, they oxidized LDL much less than untreated cells. Addition of exogenous mevalonic acid to simvastatin-treated macrophages restored their ability for superoxide production and for oxidative modification of LDL. These results indicate that simvastatin might prevent atherosclerosis by additional mechanisms besides its hypocholesterolemic activity.

引用

页码：335 / 338

页数：4

共 50 条

[31] INHIBITION OF CHOLESTEROL-SYNTHESIS BY MEVINOLIN STIMULATES LOW-DENSITY LIPOPROTEIN RECEPTOR ACTIVITY IN HUMAN MONOCYTE-DERIVED MACROPHAGES
TRABER, MG
KAYDEN, HJ
ATHEROSCLEROSIS, 1984, 52 (01) : 1 - 11
[32] New insights into the cytotoxicity of oxidized low density lipoprotein in human monocyte-derived macrophages
Asmis, R
Wintergerst, ES
ATHEROSCLEROSIS, 1997, 134 (1-2) : 220 - 220
[33] THE EFFECT OF SERUM ON LOW-DENSITY-LIPOPROTEIN METABOLISM OF HUMAN MONOCYTE-DERIVED MACROPHAGES
KOTAKE, H
OIKAWA, S
NAITO, T
HAYASAKA, K
TOYOTA, T
TOHOKU JOURNAL OF EXPERIMENTAL MEDICINE, 1993, 171 (04): : 285 - 295
[34] INVITRO GLYCATED LOW-DENSITY-LIPOPROTEIN INTERACTION WITH HUMAN MONOCYTE-DERIVED MACROPHAGES
CRERICHE, AG
DUMONT, S
SIFFERT, JC
STAHL, AJC
RESEARCH IN IMMUNOLOGY, 1992, 143 (01): : 17 - 23
[35] THE METABOLISM OF NATIVE AND MALONDIALDEHYDE-ALTERED LOW-DENSITY LIPOPROTEINS BY HUMAN MONOCYTE-MACROPHAGES
SHECHTER, I
FOGELMAN, AM
HABERLAND, ME
SEAGER, J
HOKOM, M
EDWARDS, PA
JOURNAL OF LIPID RESEARCH, 1981, 22 (01) : 63 - 71
[36] CGP-2881 INHIBITS THE OXIDATION OF LOW-DENSITY LIPOPROTEINS
FELDMAN, DL
MOGELESKY, TC
SHARIF, R
SAWYER, WK
PRESCOTT, MF
FREE RADICAL BIOLOGY AND MEDICINE, 1993, 15 (05) : 510 - 510
[37] RECEPTOR ACTIVITIES FOR LOW-DENSITY LIPOPROTEIN AND ACETYLATED LOW-DENSITY LIPOPROTEIN IN A MOUSE MACROPHAGE CELL-LINE (IC21) AND IN HUMAN MONOCYTE-DERIVED MACROPHAGES
TRABER, MG
DEFENDI, V
KAYDEN, HJ
JOURNAL OF EXPERIMENTAL MEDICINE, 1981, 154 (06): : 1852 - 1867
[38] Human monocyte-derived macrophages secrete a proteoglycan form of macrophage colony stimulating factor which binds native low density lipoproteins
Chang, MY
Olin, KL
PotterPerigo, S
Schonherr, E
Kresse, H
Wight, TN
Chait, A
CIRCULATION, 1996, 94 (08) : 2296 - 2296
[39] Oxidized low-density lipoprotein regulates matrix metalloproteinase-9 and its tissue inhibitor in human monocyte-derived macrophages
Xu, XP
Meisel, SR
Ong, JM
Kaul, S
Cercek, B
Rajavashisth, TB
Sharifi, B
Shah, PK
CIRCULATION, 1999, 99 (08) : 993 - 998
[40] Uptake and accumulation of triglyceride rich lipoproteins by monocyte-derived macrophages
Anil, E
Nova, E
Palmer, A
Yaqoob, P
ATHEROSCLEROSIS SUPPLEMENTS, 2005, 6 (01) : 165 - 165

← 1 2 3 4 5 →